Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tolerability and patient/physician satisfaction with subcutaneously administered methotrexate provided in two formulations of different drug concentrations in patients with rheumatoid arthritis.
Müller-Ladner U, Rockwitz K, Brandt-Jürgens J, Haux R, Kästner P, Braun J, Demary W, Guimbal-Schmolck C, Pichlmeier U, Brandt A; MC-MTX.10/RH Study Group. Müller-Ladner U, et al. Among authors: pichlmeier u. Open Rheumatol J. 2010 Mar 18;4:15-22. doi: 10.2174/1874312901004010015. Open Rheumatol J. 2010. PMID: 20461222 Free PMC article.
Subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience.
Demary W, Schwenke H, Rockwitz K, Kästner P, Liebhaber A, Schoo U, Hübner G, Pichlmeier U, Guimbal-Schmolck C, Müller-Ladner U. Demary W, et al. Among authors: pichlmeier u. Patient Prefer Adherence. 2014 Aug 6;8:1061-71. doi: 10.2147/PPA.S64111. eCollection 2014. Patient Prefer Adherence. 2014. PMID: 25125973 Free PMC article.
Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial.
Braun J, Kästner P, Flaxenberg P, Währisch J, Hanke P, Demary W, von Hinüber U, Rockwitz K, Heitz W, Pichlmeier U, Guimbal-Schmolck C, Brandt A; MC-MTX.6/RH Study Group. Braun J, et al. Among authors: pichlmeier u. Arthritis Rheum. 2008 Jan;58(1):73-81. doi: 10.1002/art.23144. Arthritis Rheum. 2008. PMID: 18163521 Free article. Clinical Trial.
Pediatric Acute Lymphoblastic Leukemia: Efficacy and safety of recombinant E. coli-asparaginase in infants (less than one year of age) with acute lymphoblastic leukemia.
van der Sluis I, Möricke A, Escherich G, von Stackelberg A, Holter W, Klingebiel T, Flotho C, Legien S, Tissing W, Bierings M, Guimbal-Schmolck C, Pichlmeier U, Kühnel HJ, Pieters R. van der Sluis I, et al. Among authors: pichlmeier u. Haematologica. 2013 Nov;98(11):1697-701. doi: 10.3324/haematol.2013.090563. Epub 2013 Jun 10. Haematologica. 2013. PMID: 23753025 Free PMC article. Clinical Trial.
Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy : A multicenter randomized, double-blind, placebo-controlled trial.
Stenzl A, Penkoff H, Dajc-Sommerer E, Zumbraegel A, Hoeltl L, Scholz M, Riedl C, Bugelnig J, Hobisch A, Burger M, Mikuz G, Pichlmeier U. Stenzl A, et al. Among authors: pichlmeier u. Cancer. 2011 Mar 1;117(5):938-47. doi: 10.1002/cncr.25523. Epub 2010 Nov 8. Cancer. 2011. PMID: 21351082 Free article. Clinical Trial.
Efficacy and safety of recombinant E. coli asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group.
van der Sluis IM, de Groot-Kruseman H, Te Loo M, Tissing WJE, van den Bos C, Kaspers GJL, Bierings M, Kollen WJW, König T, Pichlmeier U, Kühnel HJ, Pieters R. van der Sluis IM, et al. Among authors: pichlmeier u. Pediatr Blood Cancer. 2018 Aug;65(8):e27083. doi: 10.1002/pbc.27083. Epub 2018 May 4. Pediatr Blood Cancer. 2018. PMID: 29727043 Clinical Trial.
Pharmacokinetics, pharmacodynamics, efficacy, and safety of a new recombinant asparaginase preparation in children with previously untreated acute lymphoblastic leukemia: a randomized phase 2 clinical trial.
Pieters R, Appel I, Kuehnel HJ, Tetzlaff-Fohr I, Pichlmeier U, van der Vaart I, Visser E, Stigter R. Pieters R, et al. Among authors: pichlmeier u. Blood. 2008 Dec 15;112(13):4832-8. doi: 10.1182/blood-2008-04-149443. Epub 2008 Sep 19. Blood. 2008. PMID: 18805963 Free article. Clinical Trial.
108 results